default author photo

Emily Locke

PATH

SCHOLARLY PAPERS

2

DOWNLOADS

207

TOTAL CITATIONS

2

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

A Multi-Center, Observer-Blind, Randomized, Phase 3 Study to Evaluate Safety, Non-Inferiority of Multi-Dose and Single-Dose Vial Formulations of EuTCV (Vi-CRM197 Typhoid Conjugate Vaccine) and Lot-to-Lot Consistency of the Immune Response to Multi-Dose Vial Formulation EuTCV in Healthy Participants in Kenya and Senegal

Number of pages: 19 Posted: 24 Jan 2025
Birahim Pierre Ndiaye, Lucy Koech, Laina Mercer, John J. Aponte, Badara Cisse, Faith Riziki, Winnie Keter, Djibril Wade, Siry Diye, Niles Eaton, Emily Locke, Mike Raine, Fred Cassels, Rahsan Erdem, Gamou Fall, Moussa Dia, Ndeye S. Bob, Yeong Ok Baik, Chankyu Lee, Youngran Park, Soo Kyung Kim, Howard Lee Her and Patricia Njuguna
Institute for Health Research - Epidemiological Surveillance and Training (IRESSEF), Kenya Medical Research Institute (KEMRI) - Kenya Medical Research Institute (KEMRI)/Walter Reed Project, Institute for Disease Modeling, PATH, Institute for Health Research - Epidemiological Surveillance and Training (IRESSEF), Kenya Medical Research Institute (KEMRI), Kenya Medical Research Institute (KEMRI), Institute for Health Research - Epidemiological Surveillance and Training (IRESSEF), Institute for Health Research - Epidemiological Surveillance and Training (IRESSEF), PATH, PATH, PATH, PATH, PATH, University of Paris-Saclay - Institut Pasteur, Institut Pasteur de Dakar, Institut Pasteur de Dakar, EuBiologics R&D Center, EuBiologics R&D Center, EuBiologics R&D Center, EuBiologics R&D Center, EuBiologics R&D Center and World Health Organization (WHO) - Global Malaria Programme
Downloads 133 (547,695)

Abstract:

Loading...

Africa, Kenya, Senegal, EuTCV, Typhoid, adults, children, infants, conjugate vaccine, safety, immunogenicity, intramuscular.

2.

Safety, Tolerability and Plasmodium Falciparum Transmission-Reducing Activity of Monoclonal Antibody TB31F: An Open-Label, First-in-Human, Trial in Healthy Malaria-Naïve Adults

Number of pages: 20 Posted: 10 Mar 2022
Saskia C. van der Boor, Merel Smit, Stijn W. van Beek, Jordache Ramjith, Karina Teelen, Marga van de Vegte-Bolmer, Geert-Jan van Gemert, Peter Pickkers, Yimin Wu, Emily Locke, Shwu-Maan Lee, C. Richter King, Ashley J. Birkett, Kazutoyo Miura, Morolayo A. Ayorinde, Robert W. Sauerwein, Rob ter Heine, Christian F. Ockenhouse, Teun Bousema, Matthijs M. Jore and Matthew McCall
Radboud University Nijmegen - Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Nijmegen - Department of Medical Microbiology, Radboud University Nijmegen - Radboud University Medical Center, Radboud University Nijmegen - Radboud Institute for Health Sciences, Radboud University Nijmegen - Department of Medical Microbiology, Radboud University Nijmegen - Department of Medical Microbiology, Radboud University Nijmegen - Department of Medical Microbiology, Radboud University Nijmegen - Radboud University Medical Center, affiliation not provided to SSRN, PATH, PATH's Malaria Vaccine Initiative, affiliation not provided to SSRN, affiliation not provided to SSRN, Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), Imperial College London, TropIQ Health Sciences, Radboud University Nijmegen - Department of Pharmacy and Radboud Center for Infectious Diseases, affiliation not provided to SSRN, affiliation not provided to SSRN, Radboud University Nijmegen - Department of Medical Microbiology and Radboud University Nijmegen - Department of Medical Microbiology
Downloads 74 (844,901)
Citation 2

Abstract:

Loading...

Malaria, Plasmodium falciparum, monoclonal antibody, transmission-reducing, transmission-blocking, TB31F